1887

Journal of General Virology header logo

Volume 80, Issue 12

Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/P recombination system Free

Abstract

The HBx protein of hepatitis B virus is a multifunctional protein that is implicated in the pathogenesis of hepatocellular carcinoma by regulating gene transcription, causing cell proliferation and, as shown recently, inducing cell death. However, analysis of the effects of HBx in stable cultured cell clones has been hampered because only cell lines that adapted to the effects of HBx were selected during the establishment of cell clones. Here, we describe a system in which transcription of the X gene of hepatitis B virus is switched on by the use of the site-specific Cre recombinase. Two human liver cell lines, HLF and HepG2, were used, the former with a mutant p53 allele and the latter with wild-type p53. The stable cell clones isolated, which carried the X gene in a transcriptionally silent state, were infected with recombinant adenovirus carrying Cre recombinase. Ninety-six hours after adenovirus infection, cell clones that expressed HBx had undergone TUNEL-positive cell death with characteristics of apoptosis. Apoptosis was induced despite concomitant inactivation of the p53 protein as a result of its cytoplasmic translocation by HBx. In contrast, neither the X gene-carrying cells infected with wild-type adenovirus nor various control cells infected with Cre-expressing adenovirus exhibited apoptosis. These results indicate that the expression of HBx protein leads to liver cell apoptosis independently of the p53 pathway. The significance of HBx-induced apoptosis in natural infection is unclear, but it may contribute to the development of hepatitis and serve to spread progeny virus to neighbouring cells while evading the host immune responses.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-12-3257
1999-12-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/12/0803257.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-12-3257&mimeType=html&fmt=ahah

References

  1. Amundson S. A., Myers T. G., Fornace A. J. Jr 1998; Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 17:3287–3299
     [Google Scholar]
  2. Aufiero B., Schneider R. J. 1990; The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO Journal 9:497–504
     [Google Scholar]
  3. Avantaggiati M. L., Balsano C., Natoli G., De Marzio E., Will H., Elfassi E., Levrero M. 1992; The hepatitis B virus X protein transactivation of c-fos and c-myc proto-oncogenes is mediated by multiple transcription factors. Archives of Virology Supplementum 4:57–61
     [Google Scholar]
  4. Balsano C., Avantaggiati M. L., Natoli G., De Marzio E., Will H., Perricaudet M., Levrero M. 1991; Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the c-myc protooncogene at the transcriptional level. Biochemical and Biophysical Research Communications 176:985–992
     [Google Scholar]
  5. Benn J., Schneider R. J. 1994; Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proceedings of the National Academy of Sciences USA 91:10350–10354
     [Google Scholar]
  6. Benn J., Schneider R. J. 1995; Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proceedings of the National Academy of Sciences, USA 92:11215–11219
     [Google Scholar]
  7. Caselmann W. H. 1995; Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. Journal of Hepatology 22:34–37
     [Google Scholar]
  8. Cheong J. H., Yi M. K., Lin Y., Murakami S. 1995; Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO Journal 14:143–150
     [Google Scholar]
  9. Chirillo P., Pagano S., Natoli G., Puri P. L., Burgio V. L., Balsano C., Levrero M. 1997; The hepatitis B virus X gene induces p53-mediated programmed cell death. Proceedings of the National Academy of Sciences, USA 94:8162–8167
     [Google Scholar]
  10. Cross J. C., Wen P., Rutter W. J. 1993; Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proceedings of the National Academy of Sciences, USA 90:8078–8082
     [Google Scholar]
  11. Debbas M., White E. 1993; Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Development 7:546–554
     [Google Scholar]
  12. Evan G., Littlewood T. 1998; A matter of life and cell death. Science 281:1317–1322
     [Google Scholar]
  13. Feitelson M. A., Duan L. X. 1997; Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. American Journal of Pathology 150:1141–1157
     [Google Scholar]
  14. Ganem D., Varmus H. E. 1987; The molecular biology of the hepatitis B viruses. Annual Review of Biochemistry 56:651–693
     [Google Scholar]
  15. Gavrieli Y., Sherman Y., Ben-Sasson S. A. 1992; Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cellular Biology 119:493–501
     [Google Scholar]
  16. Haviv I., Vaizel D., Shaul Y. 1996; pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO Journal 15:3413–3420
     [Google Scholar]
  17. Hsu I. C., Tokiwa T., Bennett W., Metcalf R. A., Welsh J. A., Sun T., Harris C. C. 1993; p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 14:987–992
     [Google Scholar]
  18. Kalderon D., Roberts B. L., Richardson W. D., Smith A. E. 1984; A short amino acid sequence able to specify nuclear location. Cell 39:499–509
     [Google Scholar]
  19. Kanegae Y., Makimura M., Saito I. 1994; A simple and efficient method for purification of infectious recombinant adenovirus. Japanese Journal of Medical Science and Biology 47:157–166
     [Google Scholar]
  20. Kanegae Y., Lee G., Sato Y., Tanaka M., Nakai M., Sakaki T., Sugano S., Saito I. 1995; Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Research 23:3816–3821
     [Google Scholar]
  21. Kanegae Y., Takamori K., Sato Y., Lee G., Nakai M., Saito I. 1996; Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene 181:207–212
     [Google Scholar]
  22. Kekule A. S., Lauer U., Weiss L., Luber B., Hofschneider P. H. 1993; Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361:742–745
     [Google Scholar]
  23. Kim C. M., Koike K., Saito I., Miyamura T., Jay G. 1991; HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317–320
     [Google Scholar]
  24. Kim H., Lee H., Yun Y. 1998; X-gene product of hepatitis B virus induces apoptosis in liver cells. Journal of Biological Chemistry 273:381–385
     [Google Scholar]
  25. Koike K. 1995; Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology 38:134–142
     [Google Scholar]
  26. Koike K., Takada S. 1995; Biochemistry and functions of hepatitis B virus X protein. Intervirology 38:89–99
     [Google Scholar]
  27. Koike K., Akatsuka T., Miyamura T. 1988; Characterization of hepatitis B virus X gene: in vitro translation of mRNA from COS-1 cells transfected with the X gene. Virology 163:233–235
     [Google Scholar]
  28. Koike K., Moriya K., Iino S., Yotsuyanagi H., Endo Y., Miyamura T., Kurokawa K. 1994a; High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19:810–819
     [Google Scholar]
  29. Koike K., Moriya K., Yotsuyanagi H., Iino S., Kurokawa K. 1994b; Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. Journal of Clinical Investigation 94:44–49
     [Google Scholar]
  30. Koike K., Moriya K., Yotsuyanagi H., Shintani Y., Fujie H., Tsutsumi T., Kimura S. 1998; Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis. Cancer Letters 134:181–186
     [Google Scholar]
  31. Kwee L., Lucito R., Aufiero B., Schneider R. J. 1992; Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. Journal of Virology 66:4382–4389
     [Google Scholar]
  32. Lee T. H., Elledge S. J., Butel J. S. 1995; Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. Journal of Virology 69:1107–1114
     [Google Scholar]
  33. Miyazaki J., Takaki S., Araki K., Tashiro F., Tominaga A., Takatsu K., Yamamura K. 1989; Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene 79:269–277
     [Google Scholar]
  34. Natoli G., Avantaggiati M. L., Chirillo P., Puri P. L., Ianni A., Balsano C., Levrero M. 1994; Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 9:2837–2843
     [Google Scholar]
  35. O’Brien V. 1998; Viruses and apoptosis. Journal of General Virology 79:1833–1845
     [Google Scholar]
  36. Okuda K. 1986; Primary liver cancer. Quadrennial review lecture. Digestive Diseases and Sciences 31:133S–146S
     [Google Scholar]
  37. Pan H., Griep A. E. 1994; Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes & Development 8:1285–1299
     [Google Scholar]
  38. Paterlini P., Poussin K., Kew M., Franco D., Brechot C. 1995; Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21:313–321
     [Google Scholar]
  39. Seifer M., Hohne M., Schaefer S., Gerlich W. H. 1991; In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. Journal of Hepatology 13:S61–S65
     [Google Scholar]
  40. Shirakata Y., Kawada M., Fujiki Y., Sano H., Oda M., Yaginuma K., Kobayashi M., Koike K. 1989; The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Japanese Journal of Cancer Research 80:617–621
     [Google Scholar]
  41. Su Q., Schroder C. H., Hofmann W. J., Otto G., Pichlmayr R., Bannasch P. 1998; Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27:1109–1120
     [Google Scholar]
  42. Takada S., Kaneniwa N., Tsuchida N., Koike K. 1997; Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene 15:1895–1901
     [Google Scholar]
  43. Terradillos O., Pollicino T., Lecoeur H., Tripodi M., Gougeon M. L., Tiollais P., Buendia M. A. 1998; p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17:2115–2123
     [Google Scholar]
  44. Tiollais P., Pourcel C., Dejean A. 1985; The hepatitis B virus. Nature 317:489–495
     [Google Scholar]
  45. Twu J. S., Lai M. Y., Chen D. S., Robinson W. S. 1993; Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology 192:346–350
     [Google Scholar]
  46. Ueda H., Ullrich S. J., Gangemi J. D., Kappel C. A., Ngo L., Feitelson M. A., Jay G. 1995; Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genetics 9:41–47
     [Google Scholar]
  47. Wang X. W., Gibson M. K., Vermeulen W., Yeh H., Forrester K., Sturzbecher H. W., Hoeijmakers J. H., Harris C. C. 1995; Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Research 55:6012–6016
     [Google Scholar]
  48. Williams J. S., Andrisani O. M. 1995; The hepatitis B virus X protein targets the basic region–leucine zipper domain of CREB. Proceedings of the National Academy of Sciences, USA 92:3819–3823
     [Google Scholar]
  49. Yamada T., Yamaoka S., Goto T., Nakai M., Tsujimoto Y., Hatanaka M. 1994; The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. Journal of Virology 68:3374–3379
     [Google Scholar]
  50. Yeh P., Perricaudet M. 1997; Advances in adenoviral vectors: from genetic engineering to their biology. FASEB Journal 11:615–623
     [Google Scholar]
  51. Yu D. Y., Moon H. B., Son J. K., Jeong S., Yu S. L., Yoon H., Han Y. M., Lee C. S., Park J. S., Lee C. H., Hyun B. H., Murakami S., Lee K. K. 1999; Incidence of hepatocellular carcinoma in transgenic mice expressing hepatitis B virus X-protein. Journal of Hepatology 31:123–132
     [Google Scholar]
  52. Zoulim F., Saputelli J., Seeger C. 1994; Woodchuck hepatitis virus X protein is required for viral infection in vivo. Journal of Virology 68:2026–2030
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-12-3257
Loading
Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system
J. Gen. Virol. 80, 3257 (1999); https://doi.org/10.1099/0022-1317-80-12-3257
/content/journal/jgv/10.1099/0022-1317-80-12-3257
/content/journal/jgv/10.1099/0022-1317-80-12-3257
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error